Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics.

Schafer A, Cheng H, Xiong R, Soloveva V, Retterer C, Mo F, Bavari S, Thatcher G, Rong L.

Antiviral Res. 2018 Sep;157:47-56. doi: 10.1016/j.antiviral.2018.07.003. Epub 2018 Jul 4.

PMID:
29981374
2.

Identification of Potent Ebola Virus Entry Inhibitors with Suitable Properties for in Vivo Studies.

Liu H, Tian Y, Lee K, Krishnan P, Wang MK, Whelan S, Mevers E, Soloveva V, Dedic B, Liu X, Cunningham JM.

J Med Chem. 2018 Jul 3. doi: 10.1021/acs.jmedchem.8b00704. [Epub ahead of print]

PMID:
29920098
3.

Countering Zika Virus: The USAMRIID Response.

Lowen RG, Bocan TM, Kane CD, Cazares LH, Kota KP, Ladner JT, Nasar F, Pitt L, Smith DR, Soloveva V, Sun MG, Zeng X, Bavari S.

Adv Exp Med Biol. 2018;1062:303-318. doi: 10.1007/978-981-10-8727-1_21.

PMID:
29845541
4.

A novel sheet-like virus particle array is a hallmark of Zika virus infection.

Liu J, Kline BA, Kenny TA, Smith DR, Soloveva V, Beitzel B, Pang S, Lockett S, Hess HF, Palacios G, Kuhn JH, Sun MG, Zeng X.

Emerg Microbes Infect. 2018 Apr 25;7(1):69. doi: 10.1038/s41426-018-0071-8.

5.

Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Dong L, Garza NL, Donnelly G, Cazares LH, Nuss J, Soloveva V, Koistinen KA, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:97-104. doi: 10.1016/j.antiviral.2017.12.021. Epub 2017 Dec 28.

6.

Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Garza NL, Donnelly G, Cazares LH, Soloveva V, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:50-54. doi: 10.1016/j.antiviral.2017.12.020. Epub 2017 Dec 28.

7.

Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.

Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J.

Antiviral Res. 2018 Feb;150:112-122. doi: 10.1016/j.antiviral.2017.12.008. Epub 2017 Dec 15.

PMID:
29253498
8.

Retrovirus-Based Surrogate Systems for BSL-2 High-Throughput Screening of Antivirals Targeting BSL-3/4 Hemorrhagic Fever-Causing Viruses.

Radoshitzky SR, Soloveva V, Gharaibeh D, Kuhn JH, Bavari S.

Methods Mol Biol. 2018;1604:393-403. doi: 10.1007/978-1-4939-6981-4_29.

PMID:
28986850
9.

Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.

Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L.

Antiviral Res. 2017 Sep;145:24-32. doi: 10.1016/j.antiviral.2017.06.015. Epub 2017 Jun 20.

PMID:
28645623
10.

Flex-nucleoside analogues - Novel therapeutics against filoviruses.

Yates MK, Raje MR, Chatterjee P, Spiropoulou CF, Bavari S, Flint M, Soloveva V, Seley-Radtke KL.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2800-2802. doi: 10.1016/j.bmcl.2017.04.069. Epub 2017 Apr 22.

11.

Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.

Yi F, Guo J, Dabbagh D, Spear M, He S, Kehn-Hall K, Fontenot J, Yin Y, Bibian M, Park CM, Zheng K, Park HJ, Soloveva V, Gharaibeh D, Retterer C, Zamani R, Pitt ML, Naughton J, Jiang Y, Shang H, Hakami RM, Ling B, Young JAT, Bavari S, Xu X, Feng Y, Wu Y.

J Virol. 2017 Jun 9;91(13). pii: e02418-16. doi: 10.1128/JVI.02418-16. Print 2017 Jul 1.

12.

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.

Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross B, Wang Q, Wolfe L, Jordan R, Soloveva V, Knox J, Perry J, Perron M, Stray KM, Barauskas O, Feng JY, Xu Y, Lee G, Rheingold AL, Ray AS, Bannister R, Strickley R, Swaminathan S, Lee WA, Bavari S, Cihlar T, Lo MK, Warren TK, Mackman RL.

J Med Chem. 2017 Mar 9;60(5):1648-1661. doi: 10.1021/acs.jmedchem.6b01594. Epub 2017 Feb 14.

PMID:
28124907
13.

Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus.

Leonardi W, Zilbermintz L, Cheng LW, Zozaya J, Tran SH, Elliott JH, Polukhina K, Manasherob R, Li A, Chi X, Gharaibeh D, Kenny T, Zamani R, Soloveva V, Haddow AD, Nasar F, Bavari S, Bassik MC, Cohen SN, Levitin A, Martchenko M.

Sci Rep. 2016 Sep 30;6:34475. doi: 10.1038/srep34475.

14.

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.

Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S.

Nature. 2016 Mar 17;531(7594):381-5. doi: 10.1038/nature17180. Epub 2016 Mar 2. Erratum in: ACS Chem Biol. 2016 May 20;11(5):1463.

15.

Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting.

Zilbermintz L, Leonardi W, Jeong SY, Sjodt M, McComb R, Ho CL, Retterer C, Gharaibeh D, Zamani R, Soloveva V, Bavari S, Levitin A, West J, Bradley KA, Clubb RT, Cohen SN, Gupta V, Martchenko M.

Sci Rep. 2015 Aug 27;5:13476. doi: 10.1038/srep13476.

16.

Anti-Ebola Activity of Diazachrysene Small Molecules.

Selaković Ž, Soloveva V, Gharaibeh DN, Wells J, Šegan S, Panchal RG, Šolaja BA.

ACS Infect Dis. 2015 Jun 12;1(6):264-71. doi: 10.1021/acsinfecdis.5b00028. Epub 2015 May 4.

PMID:
27622742
17.

A high content imaging assay for identification of Botulinum neurotoxin inhibitors.

Kota KP, Soloveva V, Wanner LM, Gomba G, Kiris E, Panchal RG, Kane CD, Bavari S.

J Vis Exp. 2014 Nov 14;(93):e51915. doi: 10.3791/51915.

18.

Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.

Kiris E, Kota KP, Burnett JC, Soloveva V, Kane CD, Bavari S.

Expert Rev Mol Diagn. 2014 Mar;14(2):153-68. doi: 10.1586/14737159.2014.867808. Epub 2014 Jan 23. Review.

19.

Anti-obesity phenotypic screening looking to increase OBR cell surface expression.

Kim TH, Choi DH, Vauthier V, Dam J, Li X, Nam YJ, Ko Y, Kwon HJ, Shin SH, Cechetto J, Soloveva V, Jockers R.

J Biomol Screen. 2014 Jan;19(1):88-99. doi: 10.1177/1087057113499185. Epub 2013 Aug 19.

PMID:
23958651
20.

Phenotypic MicroRNA Microarrays.

Kwon YJ, Heo JY, Kim HC, Kim JY, Liuzzi M, Soloveva V.

Microarrays (Basel). 2013 Apr 3;2(2):63-80. doi: 10.3390/microarrays2020063.

21.

Antitumor efficacy profile of PKI-402, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.

Mallon R, Hollander I, Feldberg L, Lucas J, Soloveva V, Venkatesan A, Dehnhardt C, Delos Santos E, Chen Z, Dos Santos O, Ayral-Kaloustian S, Gibbons J.

Mol Cancer Ther. 2010 Apr;9(4):976-84. doi: 10.1158/1535-7163.MCT-09-0954. Epub 2010 Apr 6.

22.

High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.

Liu K, Samuel M, Tillett J, Hennan JK, Mekonnen B, Soloveva V, Harrison RK, Paslay JW, Larocque J.

J Biomol Screen. 2010 Feb;15(2):185-95. doi: 10.1177/1087057109356209. Epub 2009 Dec 31.

PMID:
20044579
23.

A novel high-throughput screening assay for HCN channel blocker using membrane potential-sensitive dye and FLIPR.

Vasilyev DV, Shan QJ, Lee YT, Soloveva V, Nawoschik SP, Kaftan EJ, Dunlop J, Mayer SC, Bowlby MR.

J Biomol Screen. 2009 Oct;14(9):1119-28. doi: 10.1177/1087057109345526. Epub 2009 Sep 22.

PMID:
19773585
24.

Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide).

Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, Jow F, Kramer A, Bowlby MR, Randall A, Kowal D, Gilbert A, Comery TA, Larocque J, Soloveva V, Brown J, Roncarati R.

J Pharmacol Exp Ther. 2009 Mar;328(3):766-76. doi: 10.1124/jpet.108.146514. Epub 2008 Dec 2.

25.

Ion channel screening.

Dunlop J, Bowlby M, Peri R, Tawa G, LaRocque J, Soloveva V, Morin J.

Comb Chem High Throughput Screen. 2008 Aug;11(7):514-22. Review.

PMID:
18694388
26.
27.

Nodal regulates trophoblast differentiation and placental development.

Ma GT, Soloveva V, Tzeng SJ, Lowe LA, Pfendler KC, Iannaccone PM, Kuehn MR, Linzer DI.

Dev Biol. 2001 Aug 1;236(1):124-35.

28.

Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity.

Valet P, Grujic D, Wade J, Ito M, Zingaretti MC, Soloveva V, Ross SR, Graves RA, Cinti S, Lafontan M, Lowell BB.

J Biol Chem. 2000 Nov 3;275(44):34797-802.

29.

Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity.

Soloveva V, Graves RA, Rasenick MM, Spiegelman BM, Ross SR.

Mol Endocrinol. 1997 Jan;11(1):27-38.

PMID:
8994185
30.

[STUDIES ON THE SENSITIVITY OF ENTEROPATHOGENIC COLI BACTERIA TO ANTIBIOTICS IN VITRO].

SOLOVEVA VE.

Antibiotiki. 1965 Mar;10:259-61. Russian. No abstract available.

PMID:
14294746
31.

[EFFECT OF PREPARATION OF THE ORGANISM WITH TISSUE PREPARATIONS ON ITS REACTION FOLLOWING ADMINISTRATION OF ADRENALIN SOLUTION].

SOLOVEVA VP, MANTURO NA.

Biull Eksp Biol Med. 1964 Nov;58:70-2. Russian. No abstract available.

PMID:
14313566
32.

[SIGNIFICANCE OF AXONOMETRIC ANALYSIS OF ECG IN THE EARLY STAGE OF HYPERTENSION].

SOLOVEVA VS.

Kardiologiia. 1964 May-Jun;4:71-3. Russian. No abstract available.

PMID:
14203921
33.

[BIOLOGICAL ACTIVITY OF PREPARATIONS FROM THE ANTLERS OF THE SIBERIAN STAG PRESERVED AT LOW TEMPERATURES].

SOLOVEVA VP, GARNITSKAIA LE.

Aptechn Delo. 1964 Jan-Feb;13:48-53. Russian. No abstract available.

PMID:
14152089

Supplemental Content

Loading ...
Support Center